Activity Description
Antibody-drug conjugates (ADCs) carry significant ocular risks requiring proactive management. This activity reviews evidence-based strategies for preventing and managing ADC-associated ocular adverse events, including preservative-free artificial tears, topical corticosteroids, and monitoring protocols to optimize patient comfort and treatment adherence.
The Fundingsland Group is accredited by the ACCME to provide continuing medical education for physicians.
Release Date: 05-29-2026
Expiration Date: 05-28-2027
Target Audience
This accredited educational activity is designed for ophthalmologists.
Grant Support Statement
This activity is supported by an unrestricted educational grant from AbbVie.
Faculty
